133 related articles for article (PubMed ID: 32348489)
1. Coronavirus Disease 2019: Is Everything Lawful to Create an Effective Vaccine?
Cioffi A
J Infect Dis; 2020 Jun; 222(1):169. PubMed ID: 32348489
[No Abstract] [Full Text] [Related]
2. Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2.
Plotkin SA
J Pediatric Infect Dis Soc; 2020 Nov; 9(5):517-518. PubMed ID: 32744616
[TBL] [Abstract][Full Text] [Related]
3. A vaccine is not too far for COVID-19.
Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
[No Abstract] [Full Text] [Related]
4. Audio Interview: New SARS-CoV-2 Vaccine Results, with Peter Piot.
Rubin EJ; Baden LR; Piot P; Morrissey S
N Engl J Med; 2020 Jul; 383(5):e57. PubMed ID: 32726549
[No Abstract] [Full Text] [Related]
5. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
Lodge A
Lancet; 2020 Nov; 396(10261):1486. PubMed ID: 33160564
[No Abstract] [Full Text] [Related]
6. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
Chauhan A; Agarwal A; Jaiswal N; Singh M
Lancet; 2020 Nov; 396(10261):1485-1486. PubMed ID: 33160563
[No Abstract] [Full Text] [Related]
7. COVID-19 disrupts vaccine delivery.
Nelson R
Lancet Infect Dis; 2020 May; 20(5):546. PubMed ID: 32311326
[No Abstract] [Full Text] [Related]
8. Audio Interview: Covid-19 Vaccine Development.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Jul; 383(3):e40. PubMed ID: 32668131
[No Abstract] [Full Text] [Related]
9. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
Moise L; Ross TM; Hoft DF; Martin WD; De Groot AS
Expert Rev Vaccines; 2020 Sep; 19(9):781-784. PubMed ID: 32962468
[No Abstract] [Full Text] [Related]
10. An Inactivated Virus Candidate Vaccine to Prevent COVID-19.
Mulligan MJ
JAMA; 2020 Sep; 324(10):943-945. PubMed ID: 32789500
[No Abstract] [Full Text] [Related]
11. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
Voysey M; Pollard AJ
Lancet; 2020 Nov; 396(10261):1486-1487. PubMed ID: 33160565
[No Abstract] [Full Text] [Related]
12. COVID-19 vaccine development pipeline gears up.
Mullard A
Lancet; 2020 Jun; 395(10239):1751-1752. PubMed ID: 32505245
[No Abstract] [Full Text] [Related]
13. COVID-19 vaccine trials in Africa.
Makoni M
Lancet Respir Med; 2020 Nov; 8(11):e79-e80. PubMed ID: 32896275
[No Abstract] [Full Text] [Related]
14. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.
Abu-Raya B; Gantt S; Sadarangani M
CMAJ; 2020 Aug; 192(34):E982-E985. PubMed ID: 32646869
[No Abstract] [Full Text] [Related]
15. [Not Available].
Red
MMW Fortschr Med; 2020 Apr; 162(7):56. PubMed ID: 32291653
[No Abstract] [Full Text] [Related]
16. Russian SARS-CoV-2 vaccine.
Caddy S
BMJ; 2020 Aug; 370():m3270. PubMed ID: 32839191
[No Abstract] [Full Text] [Related]
17. The Russian vaccine for COVID-19.
Burki TK
Lancet Respir Med; 2020 Nov; 8(11):e85-e86. PubMed ID: 32896274
[No Abstract] [Full Text] [Related]
18. COVID-19 vaccines: time to talk about the uncertainties.
Subbarao K
Nature; 2020 Oct; 586(7830):475. PubMed ID: 33082537
[No Abstract] [Full Text] [Related]
19. The Covid-19 Vaccine-Development Multiverse.
Heaton PM
N Engl J Med; 2020 Nov; 383(20):1986-1988. PubMed ID: 32663910
[No Abstract] [Full Text] [Related]
20. Developing a SARS-CoV-2 Vaccine at Warp Speed.
O'Callaghan KP; Blatz AM; Offit PA
JAMA; 2020 Aug; 324(5):437-438. PubMed ID: 32628244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
